Table 2.
Treatment characteristics.
| Characteristic | Statistic (n = 63) |
|---|---|
| Number of levels treated (average per patient) | 80 (1.3) |
| L2-L3 (% of patients) | 2 (3.2) |
| L3-L4 (% of patients) | 15 (23.8) |
| L4-L5 (% of patients) | 61 (96.8) |
| L5-S1 (AxiaLIF) (% of patients) | 2 (3.2) |
| Number of GII spondy levels (average per patient) | 63 (1.0) |
| Number of total levels treated per case | |
| One | 49 (77.8) |
| Two | 11 (17.5) |
| Three | 3 (4.8) |
| Graft material | |
| Beta-TCP/HA (%) | 6 (9.5) |
| DBM + allograft (%) | 6 (9.5) |
| DBM + CCC (%) | 49 (77.8) |
| Allograft cellular bone matrix (%) | 2 (3.2) |
| Supplemental fixation (GII levels) | |
| Unilateral pedicle screws (%) | 53 (84.1) |
| Bilateral pedicle screws (%) | 9 (14.3) |
| Total pedicle screw fixations (%) | 62 (98.4) |
| Transpedicular facet fixation (%) | 1 (1.6) |
| Internally fixated implant (%) | 10 (15.9) |
| No supplemental fixation (stand alone) (%) | 0 (0) |
| Mean hemoglobin change from pre- to postoperative (g) (range) | −1.4 (−3.8–0.5) |
| Mean length of hospital stay (days) (range) | 1.21 (0–4) |